moomoo ID:NaN
Log Out
  • 中文繁体
  • 中文简体

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MRKR Marker Therapeutics > Company Executives
MRKR Marker Therapeutics
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Peter L. HoangDirector, President and Chief Executive Officer1.62M----50male04/15/2022
Mr. Michael J. LoiaconoChief Accounting Officer, Treasurer and Secretary------56male04/15/2022
Dr. Juan Vera, M.D.Director, Chief Scientific Officer and Chief Operating Officer------42male04/15/2022
Mr. Anthony H. KimChief Financial Officer948.29K----46male09/27/2022
Ms. Mythili KoneruChief Medical Officer901.54K----44female04/15/2022
Ms. Tsvetelina Pencheva Hoang, PhDVice President, Research and Development------49female04/15/2022
Ms. Nadia AgopyanVice President, Regulatory Affairs------60female04/15/2022
Ms. Anna SzymanskaVice President, Quality------48female04/15/2022
Mr. Gerald GarrettVice President, Clinical Operations------57male04/15/2022
Mr. N. David EansorChairman of the Board80.00K----61male05/27/2022
Mr. Steven A. ElmsIndependent Director80.00K----58male04/15/2022
Mr. David Laskow-PooleyIndependent Director80.00K----67male04/15/2022
Mr. John WilsonIndependent Director80.00K----62male04/15/2022
Dr. Katharine Knobil, M.D.Independent Director106.36K----58female04/15/2022
Company Overview More
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
CEO: Mr. Peter L. Hoang
Market: NASDAQ
Hot List
SymbolLatest price%Chg